lupin - Latest News on lupin | Read Breaking News on Zee News

Lupin gets USFDA nod for insomnia drug

Last Updated: Monday, September 16, 2013, 18:12

"Lupin's wholly-owned US subsidiary Lupin Pharmaceuticals Inc shall commence marketing the product shortly," it added.

Lupin Q1 net up 43% at Rs 401 crore

Last Updated: Wednesday, August 7, 2013, 15:53

The company had posted a profit of Rs 280.4 crore during the same period in the previous fiscal.

Lupin gets USFDA nod for diabetes drug

Last Updated: Monday, July 22, 2013, 17:03

Drug major Lupin Monday said it has received US health regulator's approval to sell its generic version of Glumetza HCl ER Tablets, a diabetes drug, in the American market.

Lupin to market MSD's pneumonia prevention vaccine in India

Last Updated: Thursday, July 18, 2013, 12:21

Drug major Lupin Thursday said it has inked an in-licensing agreement with pharma company MSD, under which the company will market MSD's pneumonia prevention vaccine under a different brand name in India.

Lupin eyes 3-fold hike in revenues to $5 bn by 2018

Last Updated: Sunday, July 14, 2013, 11:50

In the US market, the company is aiming to strengthen its branded portfolio with the launch of additional products.

Scouting for global acquisitions of brands, companies: Lupin

Last Updated: Sunday, July 7, 2013, 18:47

For 2012-13 fiscal, the company's US revenues increased by 36 percent to USD 693 million.

Lupin eyeing acquisition route for future expansion

Last Updated: Sunday, June 30, 2013, 10:40

Drug firm Lupin Sunday said it is looking at acquisitions mainly in Latin America as it intends taking both organic and inorganic routes for future growth of the company.

Lupin expects to launch 20-25 products every year in the US

Last Updated: Sunday, May 12, 2013, 11:15

Drug major Lupin Ltd, the fifth largest generics player in the US, expects to launch 20-25 products in the American market every year in the next couple of years.

Lupin Q4 surges nearly three-fold to Rs 408 crore

Last Updated: Wednesday, May 8, 2013, 14:47

Drug major Lupin Ltd Wednesday posted nearly 3-fold increase in consolidated net profit at Rs 408.1 crore for the fourth quarter ended March 31, mainly on account of robust sales in the US and India.

Lupin voluntarily recalls anti-infectious drug from US market

Last Updated: Friday, April 26, 2013, 17:46

The nationwide recall has been initiated by the company on January, 31 this year.

Lupin expects sales to grow by around 25% in next 3 yrs

Last Updated: Sunday, April 21, 2013, 17:49

"If the past is prescriptive of the future, then we should continue to grow at the current growth levels -- clock in a minimum growth of 22-25 percent on all counts globally for the next three years," Lupin President (Finance & Planning) and CFO S Ramesh said.

Bayer evaluating options in oral contraceptive patent case

Last Updated: Friday, April 19, 2013, 16:49

German drug major Bayer AG Friday said it "disagrees" with a US court ruling that allowed Indian rival Lupin to sell generic version of its oral contraceptive (OC) tablet 'Yaz' in the American market and is "evaluating" options.